2015-05-19T08:22:08-07:00 2014-12-31 Rudd & Company PLLC 124 E Main St Rexburg ID 83440 990 2014-01-01 201829529 THE INSTITUTE FOR ETHNOMEDICINE INC INST 8013756214 PO BOX 3464 JACKSON WY 83001 PAUL ALAN COX PHD Executive Director 2015-05-19 true Justin M Taylor P00729744 2083563677 2014 2016-02-25 16:41:14Z 2882163 false false X www.ethnomedicine.org THE INSTITUTE FOR ETHNOMEDICINE SEARCHES FOR NEW CURES BY STUDYING PLANT MEDICINE AND PATTERNS OF WELLNESS AND DISEASE AMONG INDIGENOUS PEOPLE. 10 9 6 0 2106892 2873550 0 -4767 -1352 -7645 -17387 2094480 2854811 0 0 744260 810035 0 42940 1055335 1529975 1799595 2340010 294885 514801 1416514 1612652 332543 13880 1083971 1598772 THE INSTITUTE FOR ETHNOMEDICINE SEARCHES FOR NEW CURES BY STUDYING PLANT MEDICINE AND PATTERNS OF WELLNESS AND DISEASE AMONG INDIGENOUS PEOPLE. false false 2144964 Research by the Institute and members of our global scientific consortium identified the amino acid L-serine as a potential drug candidate. The Institute has studied the potential of L-serine as a novel therapy for the treatment of ALS and other neurodegenerative illnesses through in vitro and in vivo experiments, as well as FDA-approved human clinical trials. These experiments suggest that while L-serine at the doses studied cannot stop or reverse neurodegeneration associated with ALS, that L-serine may slow disease progression. 2144964 true true false false false false false false false false true false false false false false true false false false false false false false true false false false false true false false false false false false false false false false false false false false false false false false false false false true 2 0 false 6 true false false false false false false false false 0 false false false false false false false false false false X 10 9 true false false false false false false true true false false true true true true true true true false false X CINDY BUTERA 3077338377 PO BOX 1767 JACKSON WY 83001 WILLIAM C EGAN III Chairman 0.00 0.00 X 0 0 0 GORDON DEANE Director 0.00 0.00 X 0 0 0 JAMES GORTER Director 0.00 0.00 X 0 0 0 PATRICK HENRY Treasurer 0.00 0.00 X 0 0 0 DOUGLAS M KINNEY Director 0.00 0.00 X 0 0 0 MASAYUKI KISHIMOTO Director 0.00 0.00 X 0 0 0 DAVID O MACKENZIE Director 0.00 0.00 X 0 0 0 DEREK CRAIGHEAD Director 0.00 0.00 X 0 0 0 L WHITE MATTHEWS III Director 0.00 0.00 X 0 0 0 PAUL ALAN COX PHD Executive Dir. 40.00 0.00 X 189737 0 26828 SANDRA BANACK SENIOR SCIENTIST 40.00 0.00 X 151240 0 7960 340977 34788 2 false true false 0 69285 2804265 2873550 0 -1352 -1352 0 0 0 0 9965 69285 27352 -17387 0 0 0 2854811 -1352 0 0 0 0 387675 311675 76000 0 230763 230763 60980 48784 12196 92060 73648 18412 38557 33155 5402 0 0 0 0 0 0 0 0 0 0 0 0 89768 89768 0 42722 37168 5554 1495 1495 0 100114 98707 1407 0 LABORATORY EXPENSES 906110 906110 LEGAL FEES 195569 195569 SCI CONSULTANTS AND INTEL PROP 59194 41115 18079 LABORATORY RENTAL 55807 49077 6730 79196 27930 13880 37386 2340010 2144964 152106 42940 0 1097569 1095032 0 82693 0 0 0 0 0 1981960 1547034 318945 434926 0 0 0 0 1 1416514 1612652 7543 13880 325000 332543 13880 X 1083971 1596772 2000 1083971 1598772 1416514 1612652 514801 X false true X true false X 912953 1518541 1474973 2117317 2883515 8907299 0 0 912953 1518541 1474973 2117317 2883515 8907299 0 8907299 869 938 752 379 1044 3982 0 0 8911281 0.99960 0.99900 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 136595 77943 58652 1845365 1469091 376274 434926 2854811 2854811 2854811 2340010 2340010 2340010 false VARIOUS FUNDRAISING 79250 69285 9965 27352 79250 69285 9965 27352 27352 -17387 true X false false false false false false false false false false PAUL ALAN COX PHD Executive Dir. 189737 26828 216565 SANDRA BANACK SENIOR SCIENTIST 151240 7960 159200 Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, Et TWO BOARD MEMBERS PERIODICALLY DO BUSINESS TOGETHER. Form 990, Part VI, Line 11b: Form 990 Review Process COPY OF FORM 990 IS ISSUED TO ALL BOARD MEMBERS FOR REVIEW BEFORE BEING FILED. Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts Any Director, donor, or staff member who may have a conflict of interest will disclose this potential conflict to the appropriate supervisor, be it the Executive Director or Chairman of the Board. The Executive Director will disclose any of his or her conflicts to the Chairman of the board, and the Chairman will disclose any conflicts of interest to the Board of Directors. In the case of a conflict of interest of a Director, that Director will recluse himself or herself from any vote on the proposed action. In cases of related party transactions, these transactions will be approved in advance in writing by either the Executive Director or the Chairman of the board and flagged for the eternal auditors to examine during the annual audit. Directors are asked annually to disclose any conflicts of interest to the Chair, and the Chair will monitor and enforce compliance with this policy. Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management The compensation of the CEO and Executive Director will be determined by a committee composed of independent member of the Board of Directors selected by the Chairman. To assist in determining compensation, the CEO will be asked to provide comparable salary data or other professionals of similar education, trainings, and responsibility from universities and other medical research facilities. The annual compensation will be determined by the compensation committee and contemporaneous substantiation of the deliberation and decisions of the committee will be retained by the Chairman of the Board. Form 990, Part VI, Line 19: Other Organization Documents Publicly Available ALL GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST.